Ricky D Shafer

Array ( [id] => 3940586 [patent_doc_number] => 05989894 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Isolated DNA coding for spider silk protein, a replicable vector and a transformed cell containing the DNA' [patent_app_type] => 1 [patent_app_number] => 8/317844 [patent_app_country] => US [patent_app_date] => 1994-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 21 [patent_no_of_words] => 22828 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/989/05989894.pdf [firstpage_image] =>[orig_patent_app_number] => 317844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4150401 [patent_doc_number] => 06113896 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-05 [patent_title] => 'Pharmaceutical compositions containing ecotin and homologs thereof' [patent_app_type] => 1 [patent_app_number] => 8/319501 [patent_app_country] => US [patent_app_date] => 1994-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 20813 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/113/06113896.pdf [firstpage_image] =>[orig_patent_app_number] => 319501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3688823 [patent_doc_number] => 05663299 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-02 [patent_title] => 'Human monocyte elastase inhibitor' [patent_app_type] => 1 [patent_app_number] => 8/315831 [patent_app_country] => US [patent_app_date] => 1994-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 31 [patent_no_of_words] => 24973 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/663/05663299.pdf [firstpage_image] =>[orig_patent_app_number] => 315831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4021662 [patent_doc_number] => 05925557 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-20 [patent_title] => 'DNA encoding mitogen activated protein kinase, FRK' [patent_app_type] => 1 [patent_app_number] => 8/315067 [patent_app_country] => US [patent_app_date] => 1994-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 15 [patent_no_of_words] => 11199 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/925/05925557.pdf [firstpage_image] =>[orig_patent_app_number] => 315067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3803861 [patent_doc_number] => 05830743 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Process for the preparation of glutarylacylase in large quantities' [patent_app_type] => 1 [patent_app_number] => 8/312675 [patent_app_country] => US [patent_app_date] => 1994-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5754 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830743.pdf [firstpage_image] =>[orig_patent_app_number] => 312675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3647187 [patent_doc_number] => 05639645 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-17 [patent_title] => 'Recombinant .DELTA.9 desaturase and a gene encoding the same' [patent_app_type] => 1 [patent_app_number] => 8/309182 [patent_app_country] => US [patent_app_date] => 1994-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4338 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/639/05639645.pdf [firstpage_image] =>[orig_patent_app_number] => 309182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3549309 [patent_doc_number] => 05547864 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-20 [patent_title] => 'Coryneform bacteria deficient in a cell surface protein' [patent_app_type] => 1 [patent_app_number] => 8/295670 [patent_app_country] => US [patent_app_date] => 1994-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 14281 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/547/05547864.pdf [firstpage_image] =>[orig_patent_app_number] => 295670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3737975 [patent_doc_number] => 05753465 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-19 [patent_title] => 'Unmodified recombinant human adult hemoglobin production' [patent_app_type] => 1 [patent_app_number] => 8/298339 [patent_app_country] => US [patent_app_date] => 1994-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 9275 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/753/05753465.pdf [firstpage_image] =>[orig_patent_app_number] => 298339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3781420 [patent_doc_number] => 05736134 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-07 [patent_title] => 'Tissue plasminogen activator variants' [patent_app_type] => 1 [patent_app_number] => 8/244773 [patent_app_country] => US [patent_app_date] => 1994-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8583 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/736/05736134.pdf [firstpage_image] =>[orig_patent_app_number] => 244773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3539054 [patent_doc_number] => 05480800 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-02 [patent_title] => 'DNA fragment carrying the gene encoding the enzyme for fragmenting n-acetylheparosan and the adjacent sequences permitting its expression, recombinant enzyme intended for fragmenting n-acetylheparosan and its use' [patent_app_type] => 1 [patent_app_number] => 8/291896 [patent_app_country] => US [patent_app_date] => 1994-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11025 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/480/05480800.pdf [firstpage_image] =>[orig_patent_app_number] => 291896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3538956 [patent_doc_number] => 05480793 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-02 [patent_title] => 'Nucleic acid coding for the human angiotensin converting enzyme (ACE), and its uses, especially for the in vitro diagnosis of arterial hypertension' [patent_app_type] => 1 [patent_app_number] => 8/288709 [patent_app_country] => US [patent_app_date] => 1994-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 4 [patent_no_of_words] => 10891 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/480/05480793.pdf [firstpage_image] =>[orig_patent_app_number] => 288709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3441520 [patent_doc_number] => 05466595 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-14 [patent_title] => 'Calcium independent cytosolic phospholipase A2/B enzymes' [patent_app_type] => 1 [patent_app_number] => 8/281193 [patent_app_country] => US [patent_app_date] => 1994-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9077 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/466/05466595.pdf [firstpage_image] =>[orig_patent_app_number] => 281193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3924664 [patent_doc_number] => 05876970 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Surfactant compositions and methods' [patent_app_type] => 1 [patent_app_number] => 8/278189 [patent_app_country] => US [patent_app_date] => 1994-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 5448 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/876/05876970.pdf [firstpage_image] =>[orig_patent_app_number] => 278189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3765314 [patent_doc_number] => 05756093 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'Tissue plasminogen activator variants' [patent_app_type] => 1 [patent_app_number] => 8/275335 [patent_app_country] => US [patent_app_date] => 1994-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8974 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756093.pdf [firstpage_image] =>[orig_patent_app_number] => 275335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3662552 [patent_doc_number] => 05667987 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-16 [patent_title] => 'P53 response genes' [patent_app_type] => 1 [patent_app_number] => 8/274318 [patent_app_country] => US [patent_app_date] => 1994-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13750 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/667/05667987.pdf [firstpage_image] =>[orig_patent_app_number] => 274318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3686453 [patent_doc_number] => 05663142 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-02 [patent_title] => 'Protein S deletion variants deficient in C4BP binding activity, but having APC cofactor activity, compositions and therapeutic methods' [patent_app_type] => 1 [patent_app_number] => 8/267387 [patent_app_country] => US [patent_app_date] => 1994-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9200 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/663/05663142.pdf [firstpage_image] =>[orig_patent_app_number] => 267387 [rel_patent_id] =>[rel_patent_doc_number] =>)